Dr. Naga Bhavani Meduri, MD

Dr. Meduri practices at Skinpath Solutions, Inc in Smyrna, Georgia.

Dr. Meduri's NPI, 1346344405, was assigned on September 11, 2006. Dr. Meduri holds Georgia license 057104.

Dr. Meduri's primary practice is Skinpath Solutions, Inc, at 2000 Lake Park SE Dr, Smyrna, GA 30080 in Cobb County. The practice phone is (678) 556-9411.

Dr. Meduri's primary practice is Skinpath Solutions, Inc in Smyrna, Georgia. The medical group on file is Modern Dermatology Atlanta. Dmand AI also links Dr. Meduri to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meduri practices. Vendor and product names are available with a free account.

Dermatology is Dr. Meduri's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Meduri's licenses on file in 2 states: Georgia and Texas.

CMS data shows 1,003 Medicare services from Dr. Meduri across 12 procedure codes in 2024, for 301 Medicare patients. Medicare paid $52,809 for them. Every service was in an office.

CMS counts 301 Medicare patients who saw Dr. Meduri in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meduri's median patient age at 57, with 57% women.

In 2024, Dr. Meduri wrote 439 Medicare Part D claims for 190 patients. 96% of them were for generic drugs. CMS names the drug for 328 of them, across 14 drugs with 11 or more claims each, at $59,915 in total drug cost. In 2023, CMS named 279 claims across 12 drugs.

Dr. Meduri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 290 procedures of skin biopsy by Dr. Meduri, more than 90% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 89 general payments to Dr. Meduri from 23 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $262.